Annual Cash & Cash Equivalents:
$325.00M-$189.33M(-36.81%)Summary
- As of today, DOX annual cash & cash equivalents is $325.00 million, with the most recent change of -$189.33 million (-36.81%) on September 30, 2025.
- During the last 3 years, DOX annual cash & cash equivalents has fallen by -$492.98 million (-60.27%).
- DOX annual cash & cash equivalents is now -77.33% below its all-time high of $1.43 billion, reached on September 30, 2010.
Performance
DOX Cash and Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Cash & Cash Equivalents:
$325.00M-$17.47M(-5.10%)Summary
- As of today, DOX quarterly cash & cash equivalents is $325.00 million, with the most recent change of -$17.47 million (-5.10%) on September 30, 2025.
- Over the past year, DOX quarterly cash & cash equivalents has dropped by -$189.33 million (-36.81%).
- DOX quarterly cash & cash equivalents is now -79.25% below its all-time high of $1.57 billion, reached on March 31, 2004.
Performance
DOX Quarterly Cash & Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
DOX Cash and Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | -36.8% | -36.8% |
| 3Y3 Years | -60.3% | -60.3% |
| 5Y5 Years | -67.0% | -67.0% |
DOX Cash and Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | -60.3% | at low | -62.3% | +0.4% |
| 5Y | 5-Year | -67.0% | at low | -78.5% | +0.4% |
| All-Time | All-Time | -77.3% | +504.9% | -79.3% | +1695.6% |
DOX Cash and Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2025 | $325.00M(-36.8%) | $325.00M(-5.1%) |
| Jun 2025 | - | $342.47M(+5.8%) |
| Mar 2025 | - | $323.75M(-7.2%) |
| Dec 2024 | - | $349.01M(-32.1%) |
| Sep 2024 | $514.33M(-30.7%) | $514.33M(+2.4%) |
| Jun 2024 | - | $502.17M(-7.7%) |
| Mar 2024 | - | $544.36M(-9.4%) |
| Dec 2023 | - | $600.93M(-19.1%) |
| Sep 2023 | $742.53M(-9.2%) | $742.53M(-0.9%) |
| Jun 2023 | - | $749.51M(-13.0%) |
| Mar 2023 | - | $861.57M(+17.3%) |
| Dec 2022 | - | $734.56M(-10.2%) |
| Sep 2022 | $817.98M(-15.3%) | $817.98M(-3.8%) |
| Jun 2022 | - | $850.27M(-0.7%) |
| Mar 2022 | - | $856.43M(-1.4%) |
| Dec 2021 | - | $868.84M(-10.0%) |
| Sep 2021 | $965.59M(-1.9%) | $965.59M(-7.7%) |
| Jun 2021 | - | $1.05B(-10.1%) |
| Mar 2021 | - | $1.16B(-23.1%) |
| Dec 2020 | - | $1.51B(+53.8%) |
| Sep 2020 | $983.94M(+108.6%) | $983.94M(-17.6%) |
| Jun 2020 | - | $1.19B(+56.6%) |
| Mar 2020 | - | $762.60M(+57.0%) |
| Dec 2019 | - | $485.88M(+3.0%) |
| Sep 2019 | $471.63M(-9.2%) | $471.63M(+3.0%) |
| Jun 2019 | - | $457.71M(+1.8%) |
| Mar 2019 | - | $449.70M(-2.0%) |
| Dec 2018 | - | $458.65M(-11.7%) |
| Sep 2018 | $519.22M(-47.0%) | $519.22M(-7.5%) |
| Jun 2018 | - | $561.04M(-15.9%) |
| Mar 2018 | - | $666.84M(-31.0%) |
| Dec 2017 | - | $965.94M(-1.4%) |
| Sep 2017 | $979.61M(-10.6%) | $979.61M(+1.7%) |
| Jun 2017 | - | $963.04M(-16.2%) |
| Mar 2017 | - | $1.15B(+22.2%) |
| Dec 2016 | - | $940.32M(-14.2%) |
| Sep 2016 | $1.10B(-19.1%) | $1.10B(-2.6%) |
| Jun 2016 | - | $1.12B(-2.2%) |
| Mar 2016 | - | $1.15B(-3.0%) |
| Dec 2015 | - | $1.19B(-12.4%) |
| Sep 2015 | $1.35B(-4.9%) | $1.35B(-3.4%) |
| Jun 2015 | - | $1.40B(+8.5%) |
| Mar 2015 | - | $1.29B(+1.9%) |
| Dec 2014 | - | $1.27B(-10.9%) |
| Sep 2014 | $1.42B | $1.42B(+21.3%) |
| Jun 2014 | - | $1.17B(+5.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2014 | - | $1.11B(-8.5%) |
| Dec 2013 | - | $1.21B(-8.7%) |
| Sep 2013 | $1.33B(+18.6%) | $1.33B(+21.6%) |
| Jun 2013 | - | $1.09B(+11.5%) |
| Mar 2013 | - | $978.16M(+1.8%) |
| Dec 2012 | - | $961.32M(-14.0%) |
| Sep 2012 | $1.12B(-4.7%) | $1.12B(+25.1%) |
| Jun 2012 | - | $894.11M(-0.2%) |
| Mar 2012 | - | $895.55M(-3.2%) |
| Dec 2011 | - | $924.98M(-21.2%) |
| Sep 2011 | $1.17B(-18.1%) | $1.17B(+1.5%) |
| Mar 2011 | - | $1.16B(-7.6%) |
| Dec 2010 | - | $1.25B(-12.7%) |
| Sep 2010 | $1.43B(+20.2%) | $1.43B(+11.1%) |
| Jun 2010 | - | $1.29B(-5.3%) |
| Mar 2010 | - | $1.36B(+5.4%) |
| Dec 2009 | - | $1.29B(+8.3%) |
| Sep 2009 | $1.19B(-4.2%) | $1.19B(-6.8%) |
| Jun 2009 | - | $1.28B(-4.1%) |
| Mar 2009 | - | $1.33B(+7.3%) |
| Sep 2008 | $1.24B(+5.5%) | $1.24B(+5.4%) |
| Jun 2008 | - | $1.18B(+0.1%) |
| Sep 2007 | $1.18B(+20.4%) | $1.18B(+2.4%) |
| Jun 2007 | - | $1.15B(+10.8%) |
| Mar 2007 | - | $1.04B(+2.1%) |
| Dec 2006 | - | $1.02B(+4.0%) |
| Sep 2006 | $979.38M(-14.5%) | $979.38M(-18.9%) |
| Jun 2006 | - | $1.21B(+5.4%) |
| Sep 2005 | $1.15B(-11.3%) | $1.15B(-6.7%) |
| Jun 2004 | - | $1.23B(-21.6%) |
| Mar 2004 | - | $1.57B(+27.5%) |
| Dec 2003 | - | $1.23B(-4.8%) |
| Sep 2003 | $1.29B(+2302.5%) | $1.29B(+0.2%) |
| Jun 2003 | - | $1.29B(+14.3%) |
| Dec 2002 | - | $1.13B(+11.3%) |
| Jun 2002 | - | $1.01B(+136.0%) |
| Dec 2000 | - | $429.36M(+38.1%) |
| Jun 2000 | - | $310.85M(+40.1%) |
| Mar 2000 | - | $221.94M(+33.9%) |
| Dec 1999 | - | $165.80M(+94.6%) |
| Sep 1999 | - | $85.20M(+19.8%) |
| Jun 1999 | - | $71.10M(+164.3%) |
| Mar 1999 | - | $26.90M(+48.6%) |
| Dec 1998 | - | $18.10M(-28.7%) |
| Sep 1998 | - | $25.40M(-39.1%) |
| Jun 1998 | - | $41.70M |
| Sep 1997 | $53.73M | - |
FAQ
- What is Amdocs Limited annual cash & cash equivalents?
- What is the all-time high annual cash & cash equivalents for Amdocs Limited?
- What is Amdocs Limited annual cash & cash equivalents year-on-year change?
- What is Amdocs Limited quarterly cash & cash equivalents?
- What is the all-time high quarterly cash & cash equivalents for Amdocs Limited?
- What is Amdocs Limited quarterly cash & cash equivalents year-on-year change?
What is Amdocs Limited annual cash & cash equivalents?
The current annual cash & cash equivalents of DOX is $325.00M
What is the all-time high annual cash & cash equivalents for Amdocs Limited?
Amdocs Limited all-time high annual cash & cash equivalents is $1.43B
What is Amdocs Limited annual cash & cash equivalents year-on-year change?
Over the past year, DOX annual cash & cash equivalents has changed by -$189.33M (-36.81%)
What is Amdocs Limited quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of DOX is $325.00M
What is the all-time high quarterly cash & cash equivalents for Amdocs Limited?
Amdocs Limited all-time high quarterly cash & cash equivalents is $1.57B
What is Amdocs Limited quarterly cash & cash equivalents year-on-year change?
Over the past year, DOX quarterly cash & cash equivalents has changed by -$189.33M (-36.81%)